Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CSSE
|
Greenhaven Road Investment Management, L.P.
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 87,956 Reduced 20.94% |
-
|
Jan 01
2019 |
HWC
|
Joseph S Exnicios
President-Hancock Whitney Bank |
SELL
Payment of exercise price or tax liability
|
Direct | 287 Reduced 1.61% |
$9,945
$34.65 p/Share
|
Jan 01
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,860 Added 0.17% |
$119,803
$64.41 p/Share
|
Jan 01
2019 |
ALL
|
Margaret M Keane
Director |
BUY
Grant, award, or other acquisition
|
Direct | 378 Added 27.04% |
$31,234
$82.63 p/Share
|
Jan 01
2019 |
AIG
|
Seraina Macia
EVP - Blackboard |
BUY
Exercise of conversion of derivative security
|
Direct | 26,838 Added 46.01% |
-
|
Jan 01
2019 |
AIG
|
Naohiro Mouri
EVP and Chief Auditor |
BUY
Exercise of conversion of derivative security
|
Direct | 1,127 Added 44.49% |
-
|
Jan 01
2019 |
AIG
|
Douglas A. Dachille
EVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,829 Added 37.86% |
-
|
Jan 01
2019 |
AIG
|
Kevin T. Hogan
CEO, Corebridge Financial, Inc |
BUY
Exercise of conversion of derivative security
|
Direct | 30,734 Added 22.11% |
-
|
Jan 01
2019 |
AIG
|
Thomas B Leonardi
EVP-Gvt. Affairs & Policy |
BUY
Exercise of conversion of derivative security
|
Direct | 17,122 Added 46.6% |
-
|
Jan 01
2019 |
AIG
|
Alessandrea C. Quane
EVP and Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 2,629 Added 9.24% |
-
|
Jan 01
2019 |
AIG
|
Alessandrea C. Quane
EVP and Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,604 Added 20.44% |
-
|
Jan 01
2019 |
KNSL
|
Robert Lippincott Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,170 Added 9.47% |
-
|
Jan 01
2019 |
KNSL
|
Anne C. Kronenberg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,170 Added 33.9% |
-
|
Jan 01
2019 |
KNSL
|
Steven J Bensinger
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,170 Added 4.83% |
-
|
Jan 01
2019 |
KNSL
|
James Joseph Ritchie
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,170 Added 5.39% |
-
|
Jan 01
2019 |
KNSL
|
Frederick L. Russell Jr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,170 Added 33.9% |
-
|
Jan 01
2019 |
KNSL
|
Gregory M Share
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,170 Added 33.9% |
-
|
Jan 01
2019 |
ACN
|
Omar Abbosh
Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct | 2,780 Reduced 6.36% |
$390,145
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Omar Abbosh
Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 10.89% |
-
|
Jan 01
2019 |
ACN
|
Gianfranco Casati
CEO-Growth Markets |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 9.4% |
-
|
Jan 01
2019 |
ACN
|
Richard P Clark
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 165 Reduced 1.68% |
$23,156
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Richard P Clark
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,685 Added 21.43% |
-
|
Jan 01
2019 |
ACN
|
Johan Deblaere
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 212 Reduced 0.27% |
$29,752
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Johan Deblaere
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 6.45% |
-
|
Jan 01
2019 |
ACN
|
Chad T Jerdee
General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 843 Reduced 5.43% |
$118,307
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Chad T Jerdee
General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct | 3,740 Added 19.42% |
-
|
Jan 01
2019 |
ACN
|
Daniel T London
Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct | 1,712 Reduced 5.04% |
$240,262
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Daniel T London
Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 13.61% |
-
|
Jan 01
2019 |
ACN
|
Richard Lumb
Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 3.91% |
-
|
Jan 01
2019 |
ACN
|
Pierre Nanterme
Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 23,158 Added 5.88% |
-
|
Jan 01
2019 |
ACN
|
Jean Marc Ollagnier
CEO EMEA |
SELL
Payment of exercise price or tax liability
|
Direct | 43 Reduced 0.03% |
$6,035
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Jean Marc Ollagnier
CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 3.03% |
-
|
Jan 01
2019 |
ACN
|
David Rowland
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 8,728 Added 20.83% |
-
|
Jan 01
2019 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 494 Reduced 1.3% |
$69,328
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,740 Added 8.96% |
-
|
Jan 01
2019 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,336 Reduced 5.93% |
$187,494
$140.34 p/Share
|
Jan 01
2019 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 19.17% |
-
|
Jan 01
2019 |
ACN
|
Noordende Alexander M Van 'T
Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct | 5,344 Added 3.85% |
-
|
Jan 01
2019 |
ACN
|
Noordende Alexander M Van 'T
Group Chief Exec-Products |
SELL
Payment of exercise price or tax liability
|
Direct | 786 Reduced 0.59% |
$110,307
$140.34 p/Share
|
Jan 01
2019 |
SQ
|
Ajmere Dale
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 511 Reduced 0.62% |
$28,662
$56.09 p/Share
|
Jan 01
2019 |
SQ
|
Mohit Daswani
Interim CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 64 Reduced 0.07% |
$3,590
$56.09 p/Share
|
Jan 01
2019 |
SQ
|
Alyssa Henry
Square Lead |
SELL
Payment of exercise price or tax liability
|
Direct | 6,201 Reduced 1.44% |
$347,814
$56.09 p/Share
|
Jan 01
2019 |
SQ
|
Timothy Hugh Murphy
Interim CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,099 Reduced 1.81% |
$61,643
$56.09 p/Share
|
Jan 01
2019 |
SQ
|
Jacqueline D Reses
Capital Lead |
SELL
Payment of exercise price or tax liability
|
Direct | 4,290 Reduced 1.0% |
$240,626
$56.09 p/Share
|
Jan 01
2019 |
SQ
|
Sivan Whiteley
Chief Legal Ofcr. & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 2,836 Reduced 2.34% |
$159,071
$56.09 p/Share
|
Jan 01
2019 |
COF
|
Cornelis Paj Leenaars
Director |
BUY
Grant, award, or other acquisition
|
Direct | 937 Added 50.0% |
-
|
Jan 01
2019 |
NTRS
|
Linda Bynoe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6 Added 0.03% |
$502
$83.59 p/Share
|
Jan 01
2019 |
NTRS
|
Dean M Harrison
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6 Added 0.08% |
$502
$83.59 p/Share
|
Jan 01
2019 |
NTRS
|
Becerra Jose Luis Prado
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5 Added 0.05% |
$418
$83.59 p/Share
|
Jan 01
2019 |
NTRS
|
Thomas E Richards
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5 Added 0.08% |
$418
$83.59 p/Share
|
Jan 01
2019 |